Mobia Medical (NASDAQ:MOBI) Rating Increased to Strong-Buy at The Goldman Sachs Group

The Goldman Sachs Group upgraded shares of Mobia Medical (NASDAQ:MOBI) to a strong-buy rating in a research note issued to investors on Tuesday,Zacks.com reports.

MOBI has been the topic of a number of other reports. Wall Street Zen raised Mobia Medical to a “hold” rating in a research report on Saturday, May 16th. Bank of America initiated coverage on Mobia Medical in a research report on Tuesday. They set a “buy” rating and a $16.00 target price on the stock. JPMorgan Chase & Co. initiated coverage on Mobia Medical in a research report on Tuesday. They issued an “overweight” rating and a $15.00 price target for the company. BTIG Research initiated coverage on Mobia Medical in a research report on Tuesday. They issued a “buy” rating and a $19.00 price target for the company. Finally, Wolfe Research initiated coverage on Mobia Medical in a research report on Tuesday. They issued an “outperform” rating for the company. One analyst has rated the stock with a Strong Buy rating and four have given a Buy rating to the company. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $20.25.

Mobia Medical Trading Down 0.4%

Shares of NASDAQ:MOBI opened at $13.73 on Tuesday. Mobia Medical has a twelve month low of $10.19 and a twelve month high of $14.77. The company has a market cap of $454.26 million, a PE ratio of 66.00 and a beta of 2.84.

Insiders Place Their Bets

In other Mobia Medical news, Director William T. Harrington acquired 533,333 shares of Mobia Medical stock in a transaction on Monday, May 11th. The stock was purchased at an average price of $15.00 per share, for a total transaction of $7,999,995.00. Following the purchase, the director directly owned 2,006,716 shares of the company’s stock, valued at $30,100,740. This trade represents a 36.20% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Chase C. Leavitt acquired 3,000 shares of Mobia Medical stock in a transaction on Monday, May 11th. The stock was acquired at an average price of $15.00 per share, with a total value of $45,000.00. Following the purchase, the insider directly owned 3,000 shares in the company, valued at approximately $45,000. This trade represents a ? increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders bought a total of 1,268,332 shares of company stock worth $19,024,980 in the last three months.